Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Geretti

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
The Journal of Infectious Diseases|December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failureJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational StudyAnna Maria Geretti, Alexander J Stockdale, Sophie H Kelly, et al.
BMJ (Clinical Research Ed.)|August 24, 2012
Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study, David Dolling, Caroline Sabin, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistancePhilip L Tzou, Soo-Yon Rhee, Diane Descamps, et al.
Plos One|July 29, 2015
Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and BotswanaPhilippa C Matthews, Apostolos Beloukas, Amna Malik, et al.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
The Journal of Infectious Diseases|December 15, 2015
HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African AdultsPhilippa C Matthews, Jonathan M Carlson, Apostolos Beloukas, et al.
The Lancet. Public Health|March 17, 2017
Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analysesLisa S Burch, Colette J Smith, Jane Anderson, et al.
Cytokine|May 2, 2016
CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFSam Nightingale, Benedict D Michael, Martin Fisher, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2011
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort studyMattia C F Prosperi, Nicola Mackie, Simona Di Giambenedetto, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
The Journal of Infectious Diseases|December 25, 2012
Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failureJonathan Z Li, Roger Paredes, Heather J Ribaudo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational StudyAnna Maria Geretti, Alexander J Stockdale, Sophie H Kelly, et al.
BMJ (Clinical Research Ed.)|August 24, 2012
Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study, David Dolling, Caroline Sabin, et al.
The Journal of Antimicrobial Chemotherapy|October 17, 2019
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistancePhilip L Tzou, Soo-Yon Rhee, Diane Descamps, et al.
Plos One|July 29, 2015
Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and BotswanaPhilippa C Matthews, Apostolos Beloukas, Amna Malik, et al.
Journal of Neurovirology|May 20, 2016
Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemiaSam Nightingale, Anna Maria Geretti, Apostolos Beloukas, et al.
The Journal of Infectious Diseases|December 15, 2015
HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African AdultsPhilippa C Matthews, Jonathan M Carlson, Apostolos Beloukas, et al.
The Lancet. Public Health|March 17, 2017
Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analysesLisa S Burch, Colette J Smith, Jane Anderson, et al.
Cytokine|May 2, 2016
CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSFSam Nightingale, Benedict D Michael, Martin Fisher, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2011
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort studyMattia C F Prosperi, Nicola Mackie, Simona Di Giambenedetto, et al.
Pageof 18